<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>3039</number>
    <updateDate>2025-11-18T21:32:17Z</updateDate>
    <updateDateIncludingText>2025-11-18T21:32:17Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2023-10-04</introducedDate>
    <congress>118</congress>
    <legislationUrl>https://www.congress.gov/bill/118th-congress/senate-bill/3039</legislationUrl>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-10-05T00:06:51Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Federal Kratom Consumer Protection Act</title>
        <congress>118</congress>
        <number>5905</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-10-25</actionDate>
          <text>Referred to the House Committee on Energy and Commerce.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-10-04</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2023-10-04</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>L000577</bioguideId>
        <fullName>Sen. Lee, Mike [R-UT]</fullName>
        <firstName>Mike</firstName>
        <lastName>Lee</lastName>
        <party>R</party>
        <state>UT</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001288</bioguideId>
        <fullName>Sen. Booker, Cory A. [D-NJ]</fullName>
        <firstName>Cory</firstName>
        <lastName>Booker</lastName>
        <party>D</party>
        <state>NJ</state>
        <sponsorshipDate>2023-10-18</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2024-04-26T14:13:49Z</updateDate>
        </item>
        <item>
          <name>Advisory bodies</name>
          <updateDate>2024-04-26T14:12:51Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2024-04-26T14:13:38Z</updateDate>
        </item>
        <item>
          <name>Consumer affairs</name>
          <updateDate>2024-04-26T14:13:56Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2024-04-26T14:13:07Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2024-04-26T14:12:47Z</updateDate>
        </item>
        <item>
          <name>Executive agency funding and structure</name>
          <updateDate>2024-04-26T14:13:02Z</updateDate>
        </item>
        <item>
          <name>Food and Drug Administration (FDA)</name>
          <updateDate>2024-04-26T14:13:12Z</updateDate>
        </item>
        <item>
          <name>Food supply, safety, and labeling</name>
          <updateDate>2024-04-26T14:14:03Z</updateDate>
        </item>
        <item>
          <name>Government information and archives</name>
          <updateDate>2024-04-26T14:12:56Z</updateDate>
        </item>
        <item>
          <name>Research administration and funding</name>
          <updateDate>2024-04-26T14:13:43Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-10-16T21:00:19Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-10-04</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2023-10-26T19:51:12Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Federal Kratom Consumer Protection Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Federal Kratom Consumer Protection Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Federal Kratom Consumer Protection Act</title>
        <updateDate>2024-07-24T15:20:14Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Federal Kratom Consumer Protection Act</title>
        <updateDate>2024-05-24T13:36:02Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to protect access to kratom.</title>
        <updateDate>2023-10-07T04:14:00Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2023-10-04T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s3039is/xml/BILLS-118s3039is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-10-04</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
